Maria Skłodowska-Curie Institute of Oncology / Centrum Onkologii–Instytut im. Marii Skłodowskiej-Curie w Warszawie

Research facility


Location: Warsaw, Poland (PL) PL

ISNI: 0000000405402543

ROR: https://ror.org/04qcjsm24

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Salvage brachytherapy for recurrent prostate cancer after radiotherapy: An expert-endorsed review by uroGEC (2025) Gomez-Iturriaga A, Tselis N, Willisch P, Guix B, Buchser D, Chyrek A, Monge RM, et al. Journal article, Review article First-Line Camizestrant for Emerging ESR1 -Mutated Advanced Breast Cancer. (2025) Bidard FC, Mayer EL, Park YH, Janni W, Ma C, Cristofanilli M, Bianchini G, et al. Journal article Fine-mapping genomic loci refines bipolar disorder risk genes (2025) Koromina M, Ravi A, Panagiotaropoulou G, Schilder BM, Humphrey J, Braun A, Bidgeli T, et al. Journal article Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma. (2025) Wolchok JD, Chiarion-Sileni V, Rutkowski P, Cowey CL, Schadendorf D, Wagstaff J, Queirolo P, et al. Journal article A comparison of real-world data on adjuvant treatment in patients with stage III BRAF V600 mutated melanoma - Results of systematic literature research. (2025) Amaral T, Nanz L, Higuita LMS, Ascierto P, Berking C, Couselo EM, Donia M, et al. Journal article The current status of brachytherapy in Europe − A GEC-ESTRO Brachy-HERO survey (2025) Johansen JG, Jürgenliemk-Schulz IM, Haddad H, Hannoun-Levi JM, Hellebust TP, Guix B, Loessl K, et al. Journal article Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial (2024) Harbeck N, Ciruelos E, Jerusalem G, Müller V, Niikura N, Viale G, Bartsch R, et al. Journal article Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial(Nature Medicine, 10.1038/s41591-024-03261-7) (2024) Harbeck N, Ciruelos E, Jerusalem G, Müller V, Niikura N, Viale G, Bartsch R, et al. Journal article, Erratum Risks of Organ Preservation in Rectal Cancer: Data From Two International Registries on Rectal Cancer (2024) Fernandez LM, São Julião GP, Santacruz CC, Renehan AG, Cano-Valderrama O, Beets GL, Azevedo J, et al. Journal article Ribociclib plus Endocrine Therapy in Early Breast Cancer (2024) Slamon D, Lipatov O, Nowecki Z, McAndrew N, Kukielka-Budny B, Stroyakovskiy D, Yardley DA, et al. Journal article